PLANO, Texas, March 18, 2020 /PRNewswire/ -- VitalTech, a rapidly growing market leader in Telehealth and Virtual Care, announced today that it is offering health systems, physicians and their patients free Telehealth access* through their VitalCare^® platform in an effort to fight the spread of COVID-19. This initiative is implemented through a partnership with Concord Health Partners, a healthcare-focused investment firm.

As Coronavirus (COVID-19) spreads rapidly throughout the United States, Telehealth and the VitalCare Platform brings the ability to monitor and screen patients virtually for symptoms of COVID-19, and determine if a swab test is recommended. It also helps keep our most vulnerable and senior populations safer by reducing their need to leave their homes for medical visits. Telehealth also helps accomplish the CDC's request for social distancing as a means to reduce transmission and infection rates.

"Immediate and effective diagnosis and decisions need to be made delivering better and more efficient care. The VitalCare platform provides more than traditional Telehealth offerings, including real-time monitoring, communication and convenience," says James Hamilton, Chief Executive Officer of VitalTech. "As a provider of Virtual Care innovation, we feel it's incumbent upon our company at this time to help as best we can. The technology available with the VitalCare platform can help increase the safety of patients and care teams by decreasing the risk of exposure for vulnerable populations. We are grateful to Concord Health Partners for providing their support and backing on this initiative to help healthcare providers better serve their populations."

With VitalCare's HIPAA-secure platform, physicians and patients can connect online or through the app to video chat, call or message one another. Additionally, physicians are able to triage care and monitor patients' self-reported vitals, nutrition and medication intake remotely. The VitalCare app is available for iOS and Android users via the Apple App Store or the Google Play Store.

"For your highest-risk patients, you may want to talk to us about our home health kits and turn-key remote patient monitoring solutions," says Peter Ianace, Chief Operations Officer of VitalTech. "Our goal is to keep everyone as safe and healthy as possible."

"Virtual Care is an effective public health and safety tool that can help contain the spread of the Coronavirus. We are launching this initiative to provide access to the VitalCare platform in an effort to give peace of mind to and protect the health of patients, clinicians and caregivers during this time of growing uncertainty," said James Olsen, Founder and Managing Partner of Concord Health Partners.

Concord has partnered with the American Hospital Association to create the AHA Innovation Development Fund, which invests in and supports healthcare companies with innovative solutions that address affordability, quality and access. VitalTech is a portfolio company in the AHA Innovation Development Fund.

Physicians can start the simple process of signing up for the VitalCare platform by visiting www.vitaltech.com/covid-19 or calling (833) 325-5767.

*Please refer to website for complete details.

About VitalTech
VitalTech is a rapidly growing provider of fully integrated digital health solutions and smart biomedical wearables that provide real-time remote patient monitoring. Our proprietary Connected Care platform enables health systems, skilled nursing facilities, home health providers, physicians and senior living facilities to streamline workflows while improving health outcomes, increasing patient safety and lowering the cost of care. Our innovative medical grade biosensors integrate seamlessly into our suite of easy-to-use mobile devices and software, which increase patient engagement and compliance. For more information or a free consultation, please email [email protected] or visit our website at www.vitaltech.com.

About Concord Health Partners
Concord is a healthcare-focused investment firm with a strategic approach that aligns interests between investors and portfolio companies. Concord is primarily focused on investing in companies that have the potential to enhance the value of care through technologies and solutions that lower costs, improve quality and/or expand access to care. The firm, in partnership with the American Hospital Association, sponsors and manages the AHA Innovation Development Fund, a venture capital fund formed to help hospitals and health systems continue to advance health care delivery and enhance the value of care for patients and communities. For more information, please contact Concord Health Partners at 212-508-7090 or visit our website at www.concordhp.com.

Media Contacts

VitalTech
Kelly Miller
[email protected]
941-713-0082

Zoe Wood 
[email protected] 
(972) 544-7077 ext. 116

Concord Health Partners
Taylor Ingraham / Steve Bruce
ASC Advisors
[email protected] / [email protected]
203-992-1230

SOURCE VitalTech

Related Links

https://www.vitaltech.com